Savvidou Αntria et al. Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer. World Journal of Oncology, [S. l.], v. 17, n. 3, p. 380–393, 2026. DOI: 10.14740/wjon2750. Disponível em: https://wjon.elmerpub.com/wjon/article/view/2750.. Acesso em: 9 may. 2026.